SPPI - スペクトラム・ファ―マス―ティカルズ （Spectrum Pharmaceuticals Inc.）

The share price of Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) rose to $0.81 per share on Friday from $0.81. While Spectrum Pharmaceuticals Inc. has overperformed by 0.52%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, SPPI rose by 3.15%, with highs and lows ranging from $1.57 to $0.31, […]

Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI)’s traded shares stood at 1.95 million during the last session, with the company’s beta value hitting 2.13. At the close of trading, the stock’s price was $0.81, to imply an increase of 0.52% or $0.0 in intraday trading. The SPPI share’s 52-week high remains $1.57, putting it -93.83% down since that … Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI) Has Succeeded In Generating Interest In 2023, The Stock Is Up 119.81% Year-To-Date Read More »

NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Spectrum Pharmaceuticals, Inc. (“Spectrum” or the “Company”) (NASDAQ: SPPI) and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired Spectrum common stock between December 6, 2021 through September 22, 2022, inclusive (the “Class Period”). Such investors are encouraged to join this case by vi

LOS ANGELES--(BUSINESS WIRE)---- $SPPI #SPPI--The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar. New molecular entity approvals drew a blank in August. NMEs are those active moieties that have not been previously approved by the FDA. This should be a cause of concern, as NME approvals are considered a measure of innovation in drug research. The fortunate ones that could take their drugs past the finish line included bluebird bio, Inc. (NASDAQ: BLUE ), Johnson & Johnson (NYSE: JNJ ), and Axsome Therapeutics, Inc. (NASDAQ: AXSM ). ACADIA Pharmaceuticals, Inc. (NASDAQ: ACAD ) faced rejection for expanding the label of its Nuplazid to be able to treat Alzheimer’s disease psychosis. CorMedix, Inc.’s (NASDAQ: CRMD ) defencath application was shot down by the FDA for a second time. The review period for Amicus Therapeutics, Inc.’s (NASDAQ: FOLD ) Pompe disease treatment was extended. The Prescription Drug User Fee Act, or PDUFA, date is the period by which the FDA is required to rule on an application submitted by a sponsor company.

SPPI focuses on developing and commercializing novel and targeted drug products with a primary focus in oncology. Read more to see the full investment analysis.

SPPI earnings call for the period ending June 30, 2022.

Spectrum Pharma (SPPI) is trading ~9% higher after the company said the U.S. Food and Drug Administration completes re-inspection of drug substance manufacturing facility for…

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Enamoring stocks: MEI Pharma, Inc. (NASDAQ:MEIP -0.28%), Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI -5.82%) appeared first on Stocks Equity .

Spectrum Pharmaceuticals (SPPI) has announced that the resubmitted Biologics License Application for Eflapegrastim has been accepted for filing.The U.S

Veru VERU +31% after interim results for COVID-19 therapy.SailPoint Technologies SAIL +30% acquisition could lead to other cyber security deals, Wedbush says.Iveda Solutions (IVDA) +28%

Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) shares, rose in value on Thursday, 03/31/22, with the stock price up by 2.38% to the previous day’s close as strong demand from buyers drove the stock to $1.29. Actively observing the price movement in the last trading, the stock closed the session at $1.26, falling within a range of $1.25 … Looking For A Top Momentum Stock? Why Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI) Is A Great Pick Read More »

Mercurity Fintech Holding (MFH) +65%. Fast Radius (FSRD) +21%